Identifying liver cirrhosis in patients with chronic hepatitis B: an interpretable machine learning algorithm based on LSM

被引:0
作者
Bai, Xueting [1 ]
Pu, Chunwen [2 ]
Zhen, Wenchong [1 ]
Huang, Yushuang [2 ]
Zhang, Qian [1 ]
Li, Zihan [1 ]
Zhang, Yixin [1 ]
Xu, Rongxuan [1 ]
Yao, Zhihan [1 ]
Wu, Wei [1 ]
Sun, Mei [2 ]
Li, Xiaofeng [1 ]
机构
[1] Dalian Med Univ, Dept Epidemiol & Hlth Stat, 9 West Sect Lvshun Rd, Dalian, liaoning, Peoples R China
[2] Dalian Publ Hlth Clin Ctr, Dalian, Liaoning, Peoples R China
关键词
Chronic hepatitis B; liver cirrhosis; machine learning; liver stiffness measurement; diagnostic model; STIFFNESS MEASUREMENT; FIBROSIS; DIAGNOSIS; FIB-4;
D O I
10.1080/07853890.2025.2477294
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundChronic hepatitis B (CHB) is a common cause of liver cirrhosis (LC), a condition associated with an unfavourable prognosis. Therefore, timely diagnosis of LC in CHB patients is crucial.ObjectiveThis study aimed to enhance the diagnostic accuracy of LC in CHB patients by integrating liver stiffness measurement (LSM) with traditional indicators.MethodsThe study participants were randomly divided into training and internal validation sets. Employing the least absolute shrinkage and selection operator (LASSO) and random forest-recursive feature elimination (RF-RFE) for feature selection, we developed both traditional logistic regression and five machine learning models (k-nearest neighbors, random forest (RF), artificial neural network, support vector machine and eXtreme Gradient Boosting). Performance evaluation included receiver operating characteristic curves, calibration curves and decision curve analysis. Shapley additive explanations (SHAP) was employed to improve the interpretability of the optimal model.ResultsWe retrospectively included 1609 patients with CHB, among whom 470 were diagnosed with cirrhosis. Cirrhosis was diagnosed based on histological confirmation or clinical assessment, supported by characteristic findings on abdominal ultrasound and corroborative evidence such as thrombocytopenia, varices or imaging from CT/MRI. In the internal validation, the RF model achieved an accuracy above 0.80 and an AUC above 0.80, with outstanding calibration ability and clinical net benefit. Additionally, the model exhibited excellent predictive performance in an independent external validation set. The SHAP analysis indicated that LSM contributed the most to the model. The model still showed strong discriminative power when using only LSM or traditional indicators alone.ConclusionsMachine learning models, especially the RF model, can effectively identify LC in CHB patients. Integrating LSM with traditional indicators can enhance diagnostic performance.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] Predicting Hepatitis B to be acute or chronic in an infected person using machine learning algorithm
    Vijayalakshmi, C.
    Mohideen, S. Pakkir
    ADVANCES IN ENGINEERING SOFTWARE, 2022, 172
  • [32] MicroRNA profile analysis in the liver fibrotic tissues of chronic hepatitis B patients
    Chen, Rong
    Wu, Jun Cheng
    Liu, Ting
    Qu, Ying
    Lu, Lun Gen
    Xu, Ming Yi
    JOURNAL OF DIGESTIVE DISEASES, 2017, 18 (02) : 115 - 124
  • [33] Non-invasive assessment of liver fibrosis in patients with chronic hepatitis B
    Chen, Yong-Peng
    Peng, Jie
    Hou, Jin-Lin
    HEPATOLOGY INTERNATIONAL, 2013, 7 (02) : 356 - 368
  • [34] Serotonin Metabolism Parameters in Patients with Chronic Hepatitis and Liver Cirrhosis
    A. S. Alekseeva
    E. I. Beloborodova
    M. I. Rachkovskiy
    E. L. Naumova
    E. G. Lambrov
    L. P. Philippova
    Bulletin of Experimental Biology and Medicine, 2008, 146 : 577 - 579
  • [35] Serotonin Metabolism Parameters in Patients with Chronic Hepatitis and Liver Cirrhosis
    Alekseeva, A. S.
    Beloborodova, E. I.
    Rachkovskiy, M. I.
    Naumova, E. L.
    Lambrov, E. G.
    Philippova, L. P.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2008, 146 (05) : 577 - 579
  • [36] How Can We Enhance the Performance of Liver Stiffness Measurement Using FibroScan in Diagnosing Liver Cirrhosis in Patients With Chronic Hepatitis B?
    Kim, Seung Up
    Kim, Do Young
    Park, Jun Yong
    Lee, Fin Ha
    Ahn, Sang Hoon
    Kim, Ja Kyung
    Paik, Yong Han
    Lee, Kwan Sik
    Chon, Chae Yoon
    Choi, Eun Hee
    Song, Ki Jun
    Park, Young Ayun
    Han, Kwang-Hyub
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2010, 44 (01) : 66 - 71
  • [37] Diabetes mellitus as a risk factor of liver cirrhosis in patients with chronic hepatitis B virus infection
    Huo, TI
    Wu, JC
    Lee, PC
    Tsay, SH
    Chang, FY
    Lee, SD
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2000, 30 (03) : 250 - 254
  • [38] Monitoring of patients with chronic hepatitis B without liver cirrhosis while determining the tactics of treatment
    Riabokon, O. V.
    Khelemendyk, A. B.
    Riabokon, Yu. Yu.
    PATHOLOGIA, 2018, (02): : 215 - 220
  • [39] Cirrhosis, Age, and Liver Stiffness-Based Models Predict Hepatocellular Carcinoma in Asian Patients with Chronic Hepatitis B
    Lim, Jihye
    Chon, Young Eun
    Kim, Mi Na
    Lee, Joo Ho
    Hwang, Seong Gyu
    Lee, Han Chu
    Ha, Yeonjung
    CANCERS, 2021, 13 (22)
  • [40] Methotrexate is not associated with increased liver cirrhosis in a population-based cohort of rheumatoid arthritis patients with chronic hepatitis B
    Tang, Kuo-Tung
    Hung, Wei-Ting
    Chen, Yi-Hsing
    Lin, Ching-Heng
    Chen, Der-Yuan
    SCIENTIFIC REPORTS, 2016, 6